Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

NCT01490060 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma
Chemotherapy-induced Nausea and Vomiting
Effects of Chemotherapy
Adverse Effects of Medical Drugs

Interventions

DRUG: Fosaprepitant
DRUG: Dexamethasone
DRUG: 5HT3 receptor antagonist
DRUG: Ifosfamide-based chemotherapy (AI)
DRUG: Doxorubicin
DRUG: Mesna
DRUG: Ifosfamide
DRUG: Vincristine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]